bioRxiv Science⌕ Search

Biology subjects

Mykyta Artomov

Publications and source records attributed to Mykyta Artomov.

2 recordsLinked to original sources

Prioritization of disease genes from GWAS using ensemble based positive-unlabeled learning

Major complication in understanding disease biology from GWAS arises from inability to identify a complete set of causal genes. Integration of multiple omics data sources could provide an important functional link between associated variants and candidate genes. Machine-learning could take advantage of this variety of data and provide a solution for prioritization of disease genes. Yet, classical positive-negative classifiers impose strong limitations on the gene prioritization procedure, such as lack of reliable non-causal genes for training. Here, we developed a novel gene prioritization tool - Gene Prioritizer (GPrior). It is an ensemble of five positive-unlabeled bagging classifiers, that treat all genes of unknown relevance as an unlabeled set. GPrior selects an optimal combination of algorithms to tune the model for each specific phenotype. Altogether, GPrior fills an important niche of methods for GWAS data post-processing, significantly improving the ability to pinpoint disease genes compared to existing solutions.

bioinformatics↗

Mosaic Mutations in Blood DNA Sequence Are Associated with Solid Tumor Cancers

Recent findings in understanding the causal role of blood-detectable somatic protein-truncating DNA variants in leukemia prompt questions about generalizability of such observations for other cancer types. We used exome sequencing to compare 22 different cancer phenotypes from TCGA data (~8,000 samples) with more than 6,000 controls using a case-control study design and demonstrate that mosaic protein truncating variants in these genes are also associated with solid-tumor cancers. We analyzed tumor DNA samples from TCGA and observed that the cancer-associated mosaic variants are absent from the tumors.\n\nThrough analysis of different cancer phenotypes we observe gene-specificity for mosaic mutations. PPM1D in previous reports has been linked to breast and ovarian cancer, which our analysis confirms as a specifically associated to ovarian cancer. Additionally, glioblastoma, melanoma and lung cancers show gene specific burden of the mosaic protein truncating mutations. Taken together, these results extend existing observations broadly and link solid-tumor cancers to somatic blood DNA changes.

Genetics↗